AdvaMed® Statement on the FDA’s Draft Commitment Letter on the Medical Device User Fee Amendments V Agreement
The Food and Drug Administration (FDA) has released its draft commitment letter on the fifth reauthorization of the Medical Device User Fee Amendments (MDUFA), reflecting an agreement between the agency and the…
